Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CP-741,952 for Weight Loss in Obesity
NCT00367783Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CP-741,952 in obesity, sponsored by Pfizer. Started Jun 2006; status: terminated.
02
Drugs
CP-741,952
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00367783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367783.